• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Frankfurt	124,000	26.06.24 16:59:11	-0,200	-0,16%	0,000	0,000	124,000	124,200
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	73,500	26.06.24 08:24:03	-1,000	-1,34%	0,000	0,000	73,500	74,500